Johnson & Johnson will subscribe for new shares in Alligator Bioscience as part of a licensing agreement for its immuno-oncology drug candidate.
Month: January 2016
Johnson & Johnson chips in for Aelix series A
Aelix Therapeutics will use the $12.7m of funding to advance its HIV vaccine candidate through phase 2 clinical trials.
Citrix to shut down accelerator next month
The Citrix Startup Accelerator initiative, in place since 2010, will formally close down at the end of February.
SV nicks Resnick from Merck
Joshua Resnick, president and managing partner of Merck subsidiary MRL Ventures Fund for just over a year, has joined SV Life Sciences as a partner.
Startups to shape up in JJHWS accelerator
Johnson & Johnson Health and Wellness Solutions has joined forces with Plug and Play Tech Center to launch an accelerator aimed at the consumer wellness sector.
Lundbeck contributes to Iconic $40m round
The corporate venturing unit returned to back a $40m series C round for the retinal disease and cancer treatment developer, taking its overall funding to more than $70m.
Courtside Ventures kicks off with $35m
The sports-focused venture fund has $35m in capital from limited partners including WPP, and will invest in sports and media technology developers.
TiGenix aims for $57.5m to stem from IPO
The Belgium-based stem cell therapy developer, which is backed by investors including Gri-Cel and Novartis, has filed to go public in the US.
Kymeta picks up $62m signal
The Liberty Global-backed smart antenna manufacturer has closed a series D round that featured undisclosed strategic investors.
Partners Innovation Fund receives $65m boost
Partners Innovation Fund, the investment vehicle of health system Partners Healthcare (PHC), has been extended to $100m following a $65m commitment to its Partners Innovation Fund II. The cash injection came from Brigham and Women’s Hospital and Massachusetts General Hospital, two teaching hospitals of Harvard Medical School that are part of PHC’s network. The institutions… Continue reading Partners Innovation Fund receives $65m boost
Clearside eyes $57.5m IPO
The eye disease treatment developer has raised $48m in funding from investors including Santen Pharmaceutical, which is also a research partner.
Skyscanner beams in $192m
Yahoo Japan was among the new investors in a round that values the flight and travel booking service a $1.6bn.
Internet-of-things tehcnology company MMB raises $7m
NXP Semiconductor was among the investors in a series B round raised in conjunction with a strategic alliance between it and MMB Networks.
Clal draws Pi-Cardia in $10m round
Pi-Cardia will use the funding to complete development of the next generation of its aortic valve stenosis treatment technology.